Synergistic Effect of Immunotherapy and Chemotherapy in Cancers: Perspective in High Grade Glioma Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|8|513-523

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.8, 2006-01, pp. : 513-523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

By Cavaliere Robert   Newton Herbert  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 749-765

Informa Healthcare

Access to resources Recommend Favorite

Targeting ErbB Receptors in High-Grade Glioma

By  

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2468-2487

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support

By  

Current Pharmaceutical Design, Vol. 9, Iss. 3, 2003-01 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 7, 2016-05 ,pp. : 636-650

Bentham Science Publishers

Access to resources Recommend Favorite

Current and future directions for Phase II trials in high-grade glioma

By Alexander Brian M   Lee Eudocia Q   Reardon David A   Wen Patrick Y  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 369-387

Informa Healthcare

Access to resources Recommend Favorite